Literature DB >> 7114030

Clinicopathological study of alcoholic fibrosis.

A Takada, J Nei, Y Matsuda, R Kanayama.   

Abstract

Among 112 patients with alcoholic liver injury, 45 had alcoholic fibrosis. The incidence of alcoholic fibrosis was 40.2% which was the highest among various types of alcoholic liver injury (fatty liver; 3.6%, alcoholic hepatitis; 2.7% and liver cirrhosis; 31.3%). Clinical features of alcoholic fibrosis were milder than those of liver cirrhosis and more severe than those of fatty liver. The mean laboratory values in alcoholic fibrosis were significantly different from those in fatty liver and liver cirrhosis. The laboratory data were well correlated with the presence of pericellular fibrosis and thickening of the terminal hepatic venule, but only partially with hepatic cell necrosis and not with fatty metamorphosis. Two patients with alcoholic fibrosis who developed cirrhosis without any clinical and histological features of hepatitis were observed during 5-yr follow-up. These results indicate that alcoholic fibrosis is the most common type of alcoholic liver injury in Japan and is an independent clinicopathological entity distinct from the classical types of alcoholic liver injury. Pericellular fibrosis and thickening of the terminal hepatic venule which are the main histological features of alcoholic fibrosis may play an important role in its transition to liver cirrhosis.

Entities:  

Mesh:

Year:  1982        PMID: 7114030

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  8 in total

1.  Differences of liver membrane antibody frequency in alcoholic liver disease. Detection of IgG and IgA classes using radioimmunoassay.

Authors:  I Kaku; N Izumi; Y Hasumura; J Takeuchi
Journal:  Dig Dis Sci       Date:  1988-07       Impact factor: 3.199

Review 2.  The pathogenesis of alcoholic liver disease.

Authors:  R Goldin
Journal:  Int J Exp Pathol       Date:  1994-04       Impact factor: 1.925

3.  Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis.

Authors:  A Nonomura; Y Mizukami; M Unoura; K Kobayashi; Y Takeda; R Takeda
Journal:  Gastroenterol Jpn       Date:  1992-08

4.  Serum antibodies against alcohol-treated rabbit hepatocytes in patients with alcoholic liver disease.

Authors:  N Izumi; C Sato; Y Hasumura; J Takeuchi
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

5.  Lymphocyte cytotoxicity for autologous human hepatocytes in alcoholic liver disease.

Authors:  N Izumi; Y Hasumura; J Takeuchi
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

Review 6.  Characteristic features of alcoholic liver disease in Japan: a review.

Authors:  A Takada; S Takase; M Tsutsumi
Journal:  Gastroenterol Jpn       Date:  1993-02

7.  Changes in the markers related to collagen synthesis in the liver of chronically alcohol treated rats.

Authors:  S Takase; A Takada; S Urashima; K Enyama; M Fujii
Journal:  Gastroenterol Jpn       Date:  1992-02

8.  Evaluation of hepatic fibrosis by serum proline and amino-terminal type III procollagen peptide levels in alcoholic patients.

Authors:  Y Tanaka; Y Minato; Y Hasumura; J Takeuchi
Journal:  Dig Dis Sci       Date:  1986-07       Impact factor: 3.199

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.